Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

The Bulls Respond to the S&P 500 Selloff

Stocks opened yesterday with a bearish gap, yet the 50% Fibonacci retracement withstood the test, and the bulls staged a comeback. Let’s dig deeper into the health of the comeback – does it mark a reversal? S&P 500 in the Short-Run We’ll...
Monica Kingsley | May 6, 2020 |

Morning Market Outlook for Dec. 4, 2023

Stephen Whiteside of TheUpTrend.com starts the week off looking at Uber joining the S&P 500, how to respond to the VIX’s action, gold’s fluctuation and more in the Morning Market Outlook. Navigate the dynamic world of market moves ef...
TheUpTrend | December 4, 2023 |

Downside Risk in Precious Metals

Last week we noted that the risks in precious metals were primarily technical. Sentiment and technicals urge caution over the short-term. The net speculative position in Gold has remained high for months while the 21-day daily sentiment index (DSI) hit 81%. Since the s...
Jordan Roy-Byrne, CMT | February 7, 2020 |

Axsome Therapeutics Shares Open 82% Higher on Phase 3 MDD Trial Outcome

Axsome Therapeutics shares reached a new 52-week high price today after the company reported that its AXS-05 drug achieved primary endpoint in the GEMINI Phase 3 trial in Major Depressive Disorder. The firm indicated that the positive results support a New Drug Application fil...
Streetwise Reports | December 17, 2019 |

Silver Market Is at a Critical Juncture

Technical analyst Clive Maund charts his expectations for how silver prices will respond to movement in the stock market. Much of what is written in the parallel Gold Market update is equally applicable to silver and it will not be repeated here. Although silve...
Streetwise Reports | June 30, 2020 |

GBP/USD – Pound Gaining Ground as Boris Holds Lead in Polls

It’s Election Day across the U.K, and millions of voters will determine what happens next with the Brexit saga, which has lasted three years. If Prime Minister Johnson can win an outright majority, the British pound could respond with significant gains. ...
FX Empire | December 12, 2019 |

Chembio Launches COVID-19 Test that Provides Quick Results from a Simple Finger Stick

Chembio Diagnostics shares traded higher and set a new 52-week high price after the company reported that it has launched a DPP® COVID-19 serological point-of-care test which can deliver IgM/IgG antibody results in 15 minutes using a simple finger stick. ...
Streetwise Reports | April 2, 2020 |

Real Estate Crash Is The Next Shoe To Drop

The past few weeks and months have been very interesting to see how the global central banks and governments have attempted to position themselves ahead of this COVID-19 virus event. We continue to suggest that we are just starting the process of navigating through this pote...
Chris Vermeulen | April 22, 2020 |

Relmada Therapeutics Stock Soars on Phase 2 Depression Study Results

Shares of Relmada Therapeutics have traded wildly today after it announced Phase 2 results for its anti-depressant drug dextromethadone. The firm's shares have traded 100–200% higher today and the stock was halted several times trading due to extreme price volatility. ...
Streetwise Reports | October 16, 2019 |

This Is What First Lagarde’s Speech Means for Gold

In November, Lagarde delivered her first speech as the ECB President. Will she follow in Draghi’s footsteps? But what should gold investors expect from her? Key Takeaways from Lagarde’s Speech Recently, we have focused on the U.S. econo...
Arkadiusz Sieron | December 6, 2019 |
1 2 3 4 5 6